IMCR
Immunocore Holdings plc · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +10.0% ·
share flow -3.3% ·
net new positions +9.1%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 48 | -6 | 24.44M | $775.90M | +2 | −8 |
| Q1 2026 | 56 | -2 | 23.02M | $694.09M | +5 | −7 |
| Q4 2025 | 57 | +3 | 20.75M | $720.20M | +3 | n/a |
| Q3 2025 | 16 | 0 | 17.02M | $618.35M | n/a | n/a |
| Q2 2025 | 13 | 0 | 16.30M | $511.65M | n/a | n/a |
| Q1 2025 | 11 | 0 | 12.21M | $362.20M | n/a | n/a |
| Q4 2024 | 11 | +1 | 13.15M | $388.05M | +1 | n/a |
| Q3 2024 | 9 | -1 | 13.52M | $420.95M | n/a | −1 |
| Q2 2024 | 10 | n/a | 13.38M | $453.58M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.62M | -6.1% | $195.20M | 0.0% | ▼ Trim | 3 | SEC ↗ ×6 |
| 2 | PRIMECAP Management ✦ | 2.67M | +8.0% | $78.72M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.19M | +1.4% | $64.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 573.36K | -15.3% | $16.91M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Point72 Asset Management ✦ | 403.30K | New | $11.90M | 0.0% | New | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 390.80K | -34.5% | $11.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 96.57K | -65.0% | $2.85M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | State Street Global Advisors ✦ (passive) | 77.27K | n/a | $2.28M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 75.67K | +28.0% | $2.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 35.49K | +1.2% | $1.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 28.61K | -85.7% | $843,998 | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $11.90M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 141 holders, 52.39M shares, $1.48B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.